IMMUNIC, INC. — Director's Dealing 2021

Apr 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2021-04-15

Reporting Person: Nash Duane (Director, Executive Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-15	Stock Option	$15.44	A	90000	Acquired	2031-04-15	Common Stock (90000)	Direct

Footnotes

F1: The shares underlying the option vest in twelve monthly installments beginning on May 15, 2021.